References
- Hughes JM. SARS: an emerging global microbial threat. Trans Am Clin Climatol Assoc. 2004;115:361–374.
- Ledeberg J, Shope RE, Oaks SC Jr, eds., for the Committee on. Emerging microbial threats to health, division of health sciences policy, division of international health, institute of medicine. Emerging infections: microbial threats to health in the United States. Washington, DC: National Academy Press; 1992. PMID: 25121245 NBK234855. DOI:10.17226/2008.
- Smolinski MS, Hamburg MA, Lederberg J, eds, for the Committee on. Emerging microbial threats to health in the 21st century, board on global health, institute of medicine. Microbial threats to health: emergence, detection, and response. Washington, DC: National Academy Press; 2003. ISBN-10: 0-309-08864-XISBN-10: 0-309-50730-8.
- Zhong NS, Zheng BJ, Li Poon YM, et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People’s Republic of China, in February, 2003. Lancet. 2003;362:1353–1358.
- Summary of probably SARS cases with onset of illness from 1 November 2002 to 31 July 2003. World Health Organization (WHO); [cited 2020 May 30]. Available from: https://www.who.int/csr/sars/country/table2004_04_21/en/
- Zaki AM, van Boheemen S, Bestebroer TM, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814–1820.
- Hijawi B, Abdallat M, Sayaydeh A, et al. Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation. East Mediterr Health J. 2013;19(Suppl. 1):S12–S18.
- Middle east respiratory syndrome coronavirus (MERS-CoV) – saudi Arabia: between 19 and 23 April 2016, the National IHR focal point for the Kingdom of Saudi Arabia notified WHO of 3 additional cases of middle east respiratory syndrome (MERS-CoV). World Health Organization (WHO) Disease outbreak news; 2016 April 26 [cited 2020 May 30]. Available from: https://www.who.int/csr/don/26-april-2016-mers-saudi-arabia/en/
- de Wit E, van Doremalen N, Falzarano D, et al. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016 Aug;14(8):523–534.
- Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020 Apr;924:418–423. Epub 2020 Feb 7. Review.
- Petrosillo N, Viceconte G, Ergonul O, et al. COVID-19, SARS and MERS: are they closely related? Clin Microbiol Infect. 2020 Mar 28;26(6):729–734.
- GSK unveils SARS vaccine plans. The Pharma Letter; 2003 May 05 [cited 2020 May 30]. Available from: https://www.thepharmaletter.com/article/gsk-unveils-sars-vaccine-plans.
- Sanofi brings SARS experience to hunt for coronavirus vaccine By James Paton, Bloomberg February 18, 2020, 6:00 PM GMT+3; [cited 2020 May 30]. Available from: https://www.bloomberg.com/news/articles/2020-02-18/sanofi-brings-sars-experience-to-hunt-for-coronavirus-vaccine
- List of candidate vaccines developed against SARS-CoV. World Health Organization (WHO); [cited 2020 May 30]. Available from: https://www.who.int/blueprint/priority-diseases/key-action/list-of-candidate-vaccines-developed-against-sars.pdf?ua=1
- Influenza A virus subtype H1N1. From Wikipedia, the free encyclopedia; [cited 2020 May 30]. Available from: https://en.wikipedia.org/wiki/Influenza_A_virus_subtype_H1N1
- Lurie N, Saville M, Hatchett R, et al. Developing Covid-19 vaccines at pandemic speed. N Engl J Med. 2020 May 21;382(21):1969–1973. Epub 2020 Mar 30.
- Amanat F, Krammer F. SARS-CoV-2 vaccines: status report. Immunity. 2020 Apr 14;52(4):583–589. Epub 2020 Apr 6.
- Tai W, Zhang X, He X, et al. Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2. Antiviral Res. 2020 May 13;179:104820.
- Influenza H1N1 vaccine. Drugs.com; [cited 2020 May 30]. Available from: https://www.drugs.com/pro/influenza-h1n1-vaccine.html